Рациональная фармакотерапия в кардиологии
Т. 15, Вып. 2, С. 149-158
Аннотация:
Aim. To identify predictors of progression of atrial fibrillation (AF) in patients with hypertension (HT), coronary heart disease (CHD) and chronic heart failure (CHF) with recurrent AF. Material and methods. The study included 312 patients with recurrent AF. The patients were divided into 3 groups according to a leading underlying condition: essential HT (n=136), CHD (n=112), and CHF with III-IV functional class by NYHA (n=64). The average follow-up duration was 60±3 months. Progression of AF was defined as development of long-standing persistent or permanent AF. Results. All three groups of patients with recurrent AF revealed progression of the arrhythmia from paroxysmal or persistent to a sustained permanent form during the 5-year prospective follow-up. The rate of AF progression in the patients with CHF was significantly higher and accounted for 59[%] as compared to 46[%] in the patients with hypertension (p=0.002) and 51[%] in the patients with CHD (p=0.008). AF progression in patients
Ключевые слова:
Atrial fibrillation; Predictors of progression; Risk stratification
amino terminal pro brain natriuretic peptide; adult; arterial stiffness; Article; comparative study; controlled study; disease exacerbation; endothelial dysfunction; female; follow up; heart arrhythmia; heart failure; heart infarction; heart left ventricle ejection fraction; heart left ventricle hypertrophy; heart ventricle wall motion; human; hypertension; ischemic heart disease; major clinical study; male; medical history; middle aged; New York Heart Association class; permanent atrial fibrillation; persistent atrial fibrillation; prediction; protein blood level; pulse wave; recurrent disease; sinus rhythm; systolic heart failure
Подзолков В. И. Валерий Иванович 1948-
Тарзиманова А. И. Аида Ильгизовна 1978-
Podzolkov V. I. Valerij Ivanovich 1948-
Tarzimanova A. I. Aida Il`gizovna 1978-
Current predictors of atrial fibrillation progression
Текст визуальный непосредственный
Рациональная фармакотерапия в кардиологии
Столичная издательская компания
Т. 15, Вып. 2 С. 149-158
2019
Статья
Atrial fibrillation Predictors of progression Risk stratification
amino terminal pro brain natriuretic peptide adult arterial stiffness Article comparative study controlled study disease exacerbation endothelial dysfunction female follow up heart arrhythmia heart failure heart infarction heart left ventricle ejection fraction heart left ventricle hypertrophy heart ventricle wall motion human hypertension ischemic heart disease major clinical study male medical history middle aged New York Heart Association class permanent atrial fibrillation persistent atrial fibrillation prediction protein blood level pulse wave recurrent disease sinus rhythm systolic heart failure
Aim. To identify predictors of progression of atrial fibrillation (AF) in patients with hypertension (HT), coronary heart disease (CHD) and chronic heart failure (CHF) with recurrent AF. Material and methods. The study included 312 patients with recurrent AF. The patients were divided into 3 groups according to a leading underlying condition: essential HT (n=136), CHD (n=112), and CHF with III-IV functional class by NYHA (n=64). The average follow-up duration was 60±3 months. Progression of AF was defined as development of long-standing persistent or permanent AF. Results. All three groups of patients with recurrent AF revealed progression of the arrhythmia from paroxysmal or persistent to a sustained permanent form during the 5-year prospective follow-up. The rate of AF progression in the patients with CHF was significantly higher and accounted for 59[%] as compared to 46[%] in the patients with hypertension (p=0.002) and 51[%] in the patients with CHD (p=0.008). AF progression in patients